ObsEva SA
Clinical-stage biopharma for women's health, now winding down operations.
OBSN | SW
Overview
Corporate Details
- ISIN(s):
- CH1260041939
- LEI:
- 549300PNZ0UEJVKN1618
- Country:
- Switzerland
- Address:
- CHEMIN DES AULX 12, 1228 PLAN-LES-OUATES
- Website:
- https://www.obseva.com/
- Sector:
- Manufacturing
Description
ObsEva SA is a clinical-stage biopharmaceutical company that was focused on the development and commercialization of novel therapeutics for women's reproductive health and pregnancy. The company's primary development program was centered on improving in vitro fertilization (IVF) success rates with its product candidate, nolasiban. In February 2024, ObsEva announced that it was winding down its operations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ObsEva SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ObsEva SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ObsEva SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-17 | N/A | Non-Executive member | Buy | None | 2,058.00 CHF |
| 2022-03-16 | N/A | Non-Executive member | Buy | None | 27,010.00 CHF |
| 2022-03-15 | N/A | Non-Executive member | Buy | None | 23,642.00 CHF |
| 2022-02-08 | N/A | Non-Executive member | Buy | None | 64,161.00 CHF |
| 2022-02-01 | N/A | Non-Executive member | Buy | None | 70,716.00 CHF |
| 2022-01-24 | N/A | Non-Executive member | Buy | None | 69,748.00 CHF |
| 2022-01-11 | N/A | Non-Executive member | Buy | None | 183,535.00 CHF |
| 2022-01-10 | N/A | Non-Executive member | Buy | None | 177,643.00 CHF |
Peer Companies
